More
    Guided Solutions - Connecting Talent With Innovation/div>

    French medtech BioSerenity bags €24M to help doctors use AI for diagnoses

    Jolt Capital, a French private equity firm that pumps in growth investment in European deeptech companies has invested €24 million in BioSerenity, a French medtech startup. The company developes solutions...

    Gilde Healthcare closes new Venture&Growth fund at €740 million hard cap

    Gilde Healthcare Venture&Growth VI closes at its hard cap with €740 million from a balanced mix of international investors Gilde Healthcare invests in fast growing companies...

    Pantheon Vision launches with $2.5m to develop bioengineered corneal implants

    Pantheon Vision has launched with $2.5m in seed funding to develop bioengineered corneal implants to treat corneal blindness. The US-based ophthalmic device company was established...

    University of Nottingham secures £1.1m for trial of first iTraXs

    The University of Nottingham has secured £1.1 million in funding from the Medical Research Council to undertake human trials for the world’s first optical...

    Elucid closes $80m Series C for AI cardiovascular risk diagnostic tool

    Elucid has raised $80m in a Series C financing round led by Elevage Medical Technologies to advance its artificial intelligence (AI)-powered diagnostic tools. The funding,...

    Heart Failure start-up, Acorai, secures €2.3m grant funding from the European Commission

    Today, Acorai, a start-up medical device manufacturer from Sweden, announces selection for a €2.3m grant with a follow-on €10m investment offer from the European Innovation Council...

    Elekta Secures $40M Order for Radiation Technology

    Elekta announced today that it received an order worth approximately $40 million for its full suite of hardware and software. Stockholm, Sweden-based Elekta develops precision radiation...

    AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth...

    Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed $40 million funded at close; $50 million of additional...

    Gynesonics secures $42.5m for uterine fibroids device expanded rollout

    Women’s healthcare company Gynesonics has secured $42.5m in financing to help further commercialise its Sonata technology. The round, led by existing investors Amzak Health, Endeavour...

    Latest articles